Cargando…

Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study

OBJECTIVES: After regulatory approval, drug companies, public funding agencies and academic researchers often pursue trials aimed at extending the uses of a new drug by testing it in new non-approved indications. Patient burden and clinical impact of such research are not well understood. DESIGN AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlisle, Benjamin Gregory, Doussau, Adélaïde, Kimmelman, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Ethics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044865/ https://www.ncbi.nlm.nih.gov/pubmed/32071183 http://dx.doi.org/10.1136/bmjopen-2019-034306

Ejemplares similares

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa
por: Limaye, Dnyanesh, et al.
Publicado: (2015)

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
por: Miller, Jennifer E, et al.
Publicado: (2017)

Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial protocols
por: Paludan-Müller, Asger Sand, et al.
Publicado: (2019)

TwiC or treat? Are trials within cohorts ethically defensible?
por: Weijer, Charles, et al.
Publicado: (2017)

Advance consent for participation in randomised controlled trials for emergency conditions: a scoping review
por: Niznick, Naomi, et al.
Publicado: (2023)

Advanced consent for participation in acute care randomised control trials: protocol for a scoping review
por: Niznick, Naomi, et al.
Publicado: (2020)

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015)

Kidney Dyads: Caregiver Burden and Relationship Strain Among Partners of Dialysis and Transplant Patients
por: Van Pilsum Rasmussen, Sarah E., et al.
Publicado: (2020)

Dissemination of trial results to participants in phase III pragmatic clinical trials: an audit of trial investigators intentions
por: Raza, M Zulfiqar, et al.
Publicado: (2020)

When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members
por: Mhaskar, Rahul, et al.
Publicado: (2016)

Improved parental understanding by an enhanced informed consent form: a randomized controlled study nested in a paediatric drug trial
por: Koonrungsesomboon, Nut, et al.
Publicado: (2019)

Advance directives in the emergency department
por: Baker, Eileen F., et al.
Publicado: (2020)

Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
por: Fisher, Jill A, et al.
Publicado: (2021)

Readability and understandability of clinical research patient information leaflets and consent forms in Ireland and the UK: a retrospective quantitative analysis
por: O'Sullivan, Lydia, et al.
Publicado: (2020)

Informal professionalization of healthy participants in phase I clinical trials in Russia
por: Zvonareva, Olga, et al.
Publicado: (2019)

Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study
por: Morrow, Richard L, et al.
Publicado: (2023)

Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
por: Mattina, James, et al.
Publicado: (2017)

Registration audit of clinical trials given a favourable opinion by UK research ethics committees
por: Denneny, Carla, et al.
Publicado: (2019)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020)

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases
por: Ismail, Rawa K., et al.
Publicado: (2020)

Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
por: Jones, Christopher W, et al.
Publicado: (2016)

Why articles are retracted: a retrospective cross-sectional study of retraction notices at BioMed Central
por: Moylan, Elizabeth C, et al.
Publicado: (2016)

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
por: Ozaki, Akihiko, et al.
Publicado: (2019)

Prospective registration trends, reasons for retrospective registration and mechanisms to increase prospective registration compliance: descriptive analysis and survey
por: Hunter, Kylie Elizabeth, et al.
Publicado: (2018)

Doctors’ perspectives on adhering to advance care directives when making medical decisions for patients: an Australian interview study
por: Moore, Nadia, et al.
Publicado: (2019)

Best Case/Worst Case: protocol for a multisite randomised clinical trial of a scenario planning intervention for patients with kidney failure
por: Haug, Karlie, et al.
Publicado: (2022)

How do community advisory boards fulfil their ethical role in HIV clinical trials? A protocol for a systematic review of qualitative evidence
por: Pancras, Godwin, et al.
Publicado: (2020)

Family bereavement and organ donation in Spain: a mixed method, prospective cohort study protocol
por: Martinez-Lopez, Maria Victoria, et al.
Publicado: (2023)

Informed consent in cluster randomised trials: a guide for the perplexed
por: Nix, Hayden P, et al.
Publicado: (2021)

Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
por: Chappuy, Hélène, et al.
Publicado: (2013)

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
por: Axson, Sydney A, et al.
Publicado: (2021)

The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis
por: Lawrence, David S, et al.
Publicado: (2021)

Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
por: Shearman, Kirstie, et al.
Publicado: (2022)

Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021)

Details of risk–benefit communication in informed consent documents for phase I/II trials
por: Kahrass, Hannes, et al.
Publicado: (2020)

Protocol for a systematic scoping review of reasons given to justify the performance of randomised controlled trials
por: Dewar, Brian, et al.
Publicado: (2019)

Which moral barriers and facilitators do physicians encounter in advance care planning conversations about the end of life of persons with dementia? A meta-review of systematic reviews and primary studies
por: Keijzer-van Laarhoven, Angela JJM, et al.
Publicado: (2020)

Rationalisations for women-only randomised controlled trials in conditions that affect both sexes: a scoping review protocol
por: Matthewson, Ainsley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5m1gvj4cgg5qv0gm4m9lbr40mm